Articles by Laura Tabellini Pierre

About Laura

Laura Tabellini Pierre, MSc, is a scientific and technical writer at Parse Biosciences with extensive experience in immunology, encompassing both academic and R&D research.

Leading with Compassion and Data: Ethical Science Powered by scRNA-Seq and Non-Animal Models

Dec 1, 2025

Researcher Amy Van Aartsen shares how Evercode™ scRNA-seq has propelled her research and highlights her work with The Marty Project.

From Animal Testing to Organoids: The New Era of Human-Based Drug Development

Nov 13, 2025

The FDA’s move to phase out animal testing marks a pivotal shift in drug development, opening the door for human-based models like organoids and organ-on-a-chip systems to drive safer, more precise, and patient-relevant discoveries.

From Blurred to Precise: scRNA-Seq Brings Clarity and Direction to legacy GWAS data

Sep 10, 2025

By combining Genome-wide association studies (GWAS) with gene expression and single cell sequencing, researchers can connect genetic variation to molecular mechanisms, uncovering how specific cell types drive disease risk.

Master Your Data Analysis: Insider Tips to Get the Most Out of Trailmaker

Jul 1, 2025

Trailmaker is a flexible, user-friendly tool that supports a wide range of single cell RNA sequencing analysis workflows, whether you’re starting from scratch or integrating with existing pipelines.

Demystifying Single Cell Analysis with Trailmaker

Jun 25, 2025

With Trailmaker, both wet-lab scientists and bioinformaticians are empowered to streamline their single cell analysis from data upload to visualization through an intuitive, collaborative platform.

The Single Cell Solution Immunology Has Been Waiting For

May 16, 2025

To keep up with the complexity of immune research, newer single cell technologies like combinatorial barcoding offer a robust alternative to droplet-based techniques.

Advancing Cancer Research: The Role of scRNA-seq in Unraveling Complexity and Driving Progress

Apr 24, 2025

Single cell RNA sequencing is transforming cancer research by uncovering hidden complexities like drug resistance and tumor heterogeneity, highlighting the need for continued innovation to outpace cancer’s evolution and improve patient outcomes.

Translating the Cross-Talk Between Tumor Microenvironment and Cancer Stem Cells

Apr 18, 2025

With the development of new multi-omics technologies, researchers can explore new avenues for therapeutic interventions and precision medicine in cancer research.

Science in the Time of Uncertainty

Apr 5, 2025

As the scientific community faces challenges such as funding uncertainty and policy changes, we remember to look to history, proving that science has always thrived in uncertainty. Even in the face of setbacks, it endures through those who keep asking questions.

Single Cell Sequencing and The Future of Drug Discovery

Feb 27, 2025

Discover how single-cell RNA sequencing is transforming drug development, reducing costs and timelines while improving success rates. Learn about the latest breakthroughs in pharmaceutical research.

Whole Transcriptome

Immune Profiling

Additional Capabilities

Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Milli...

Parse Biosciences Launches Evercode Whole Blood Fixation

Technology

The end-to-end solution

Products